(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ENSURGE MICROPOWER, BIC, and EQVA.

Financial Asset	Price	Change	Updated (EST)
ENSURGE MICROPOWER (ENSU.OL)	0.31	55.16%	2024-02-20 12:25:54
BIC (BB.PA)	68.20	9.14%	2024-02-20 13:00:24
EQVA (EQVA.OL)	3.13	7.93%	2024-02-20 12:26:00
MITHRA (MITRA.BR)	0.60	7.72%	2024-02-20 12:20:39
AIR LIQUIDE (AI.PA)	184.10	7.24%	2024-02-20 12:45:11
ITERA (ITERA.OL)	12.85	5.33%	2024-02-20 12:40:39
ULTIMOVACS (ULTI.OL)	154.20	4.9%	2024-02-20 12:44:03
VERIMATRIX (VMX.PA)	0.54	4.82%	2024-02-20 13:24:29
LUMIBIRD (LBIRD.PA)	12.90	4.71%	2024-02-20 13:06:02
MEMSCAP REGPT (MEMS.PA)	8.52	4.42%	2024-02-20 13:20:16

The three biggest losers today are PROACTIS SA, VALNEVA, and NORTHERN DRILLING.

Financial Asset	Price	Change	Updated (EST)
PROACTIS SA (PROAC.PA)	0.06	-11.68%	2024-02-20 13:21:40
VALNEVA (VLA.PA)	3.32	-8.89%	2024-02-20 13:24:19
NORTHERN DRILLING (NODL.OL)	0.44	-8.54%	2024-02-20 12:41:35
BERGENBIO (BGBIO.OL)	0.20	-8.45%	2024-02-20 12:25:01
EVERGREEN (EGR.PA)	1.98	-7.91%	2024-02-20 13:03:14
VITURA (VTR.PA)	10.50	-7.89%	2024-02-20 13:24:41
METABOLIC EXPLORER (METEX.PA)	0.35	-7.78%	2024-02-20 13:20:23
ATOS (ATO.PA)	2.18	-7.34%	2024-02-20 12:45:55
FUT.CLUBE PORTO (FCP.LS)	1.14	-7.32%	2024-02-20 12:23:13
FERMENTALG (FALG.PA)	0.72	-6.75%	2024-02-20 13:03:32

Winners today

1. ENSURGE MICROPOWER (ENSU.OL)

55.16% Price Change

Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 55.16% to €0.31 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.35% to €1,262.81, after three consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.5.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ENSURGE MICROPOWER’s EBITDA is -150.46.

More news about ENSURGE MICROPOWER.

2. BIC (BB.PA)

9.14% Price Change

Société BIC SA manufactures and sells stationery, lighter, shaver, and other products worldwide. It offers ball and coloring felt pens, gel ink pens, markers, sticky notes, leads, whiteboards, and correction tapes, as well as graphite, coloring, mechanical, and other pencils; reusable notebooks, digital slates, and smart pens; art and craft kits; permanent and temporary tattoo markers; and pen and pencil refills. The company also provides refillable shavers and razors; and pocket, utility, and decorated lighters. In addition, it sells batteries and shaving preps; and advertising and promotional products. Further, the company is involved in the provision of delivery services; production of industrial equipment; and manufacture and distribution of IT solutions and consumer products, as well as in real estate and insurance activities. It markets its products primarily under the BIC, BIC Kids, Cello, Lucky, RocketBook, Tipp-Ex, BIC Wite-Out, Tattly, ami, DJEEP, InkBox, BIC Soleil, BIC Evolution, and BodyMark brands through a range of channels, including retail mass-market distributors, traditional stores, and office product stationers, as well as an e-commerce site. The company was founded in 1944 and is headquartered in Clichy, France.

CAC 40 ended the session with BIC rising 9.14% to €68.20 on Tuesday while CAC 40 rose 0.34% to €7,795.22.

Earnings Per Share

As for profitability, BIC has a trailing twelve months EPS of €4.36.

PE Ratio

BIC has a trailing twelve months price to earnings ratio of 15.64. Meaning, the purchaser of the share is investing €15.64 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.82%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 29, 2023, the estimated forward annual dividend rate is 2.56 and the estimated forward annual dividend yield is 4.04%.

More news about BIC.

3. EQVA (EQVA.OL)

7.93% Price Change

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA rising 7.93% to €3.13 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 0.35% to €1,262.81, after three consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 209.8%, now sitting on 594.65M for the twelve trailing months.

Moving Average

EQVA’s value is above its 50-day moving average of kr2.92 and higher than its 200-day moving average of kr3.07.

Yearly Top and Bottom Value

EQVA’s stock is valued at kr3.13 at 21:40 EST, way below its 52-week high of kr4.00 and way higher than its 52-week low of kr2.56.

More news about EQVA.

4. MITHRA (MITRA.BR)

7.72% Price Change

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

BEL 20 ended the session with MITHRA rising 7.72% to €0.60 on Tuesday while BEL 20 dropped 0.44% to €3,668.88.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-1.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -575.59%.

Volume

Today’s last reported volume for MITHRA is 302089 which is 32.7% above its average volume of 227643.

Moving Average

MITHRA’s value is way below its 50-day moving average of €1.06 and way below its 200-day moving average of €1.67.

More news about MITHRA.

5. AIR LIQUIDE (AI.PA)

7.24% Price Change

L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. The Gas & Services segment comprises large industries business, which offers gas and energy solutions including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, as well as operates cogeneration plants to supply steam and electricity to metals, chemicals, refining, and energy industries; and industrial merchant business line provides industrial gases, equipment, hardgoods, and associated services to material and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and craftsmen and retail sector. This segment also includes healthcare business, which provides medical gases, home healthcare services, medical equipment, and specialty ingredient to patients, healthcare professionals, and hospitals; and electronic business supply carrier gases, electronic specialty and advanced materials, equipment and installation, and service to semiconductor, flat panel, and photovoltaic markets. Its Engineering & Construction segment designs, develops, and builds industrial gas production plants to third parties; and design and manufacture plants in traditional, renewable and alternative energy sectors. The Global Markets & Technologies segment delivers technological solutions, such as molecules, equipment, and services to energy transition, primarily in transport, energy, and waste valorization, as well as space exploration, aerospace, fundamental sciences, and quantum computing. This segment also invests in biomethane production units; develops stations for distributing natural biogas for vehicles and hydrogen; operates biomethane production units for maritime industry; and supplies gases for the offshore oil and gas platforms, offshore wind turbines, and cryogenic transportation by sea. L'Air Liquide S.A. was incorporated in 1902 and is headquartered in Paris, France.

CAC 40 ended the session with AIR LIQUIDE rising 7.24% to €184.10 on Tuesday, after two consecutive sessions in a row of gains. CAC 40 rose 0.34% to €7,795.22, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, AIR LIQUIDE has a trailing twelve months EPS of €6.08.

PE Ratio

AIR LIQUIDE has a trailing twelve months price to earnings ratio of 30.28. Meaning, the purchaser of the share is investing €30.28 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.73%.

More news about AIR LIQUIDE.

6. ITERA (ITERA.OL)

5.33% Price Change

Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ITERA jumping 5.33% to €12.85 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.35% to €1,262.81.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.76.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 16.91. Meaning, the purchaser of the share is investing kr16.91 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 116.49%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 38.1% and a drop 56.7% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ITERA’s EBITDA is 58.57.

Volatility

ITERA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.49%, a negative 0.27%, and a positive 2.96%.

ITERA’s highest amplitude of average volatility was 6.05% (last week), 2.58% (last month), and 2.96% (last quarter).

Volume

Today’s last reported volume for ITERA is 12887 which is 71.71% below its average volume of 45559.

More news about ITERA.

7. ULTIMOVACS (ULTI.OL)

4.9% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS jumping 4.9% to €154.20 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI slid 0.35% to €1,262.81, after three successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-6.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.94%.

More news about ULTIMOVACS.

8. VERIMATRIX (VMX.PA)

4.82% Price Change

Verimatrix SA provides security solutions that protect digital content, applications, and devices worldwide. It offers anti-piracy products, including Streamkeeper Pro, which safeguards the OTT content distribution ecosystem by disrupting pirate revenue streams; Streamkeeper Multi-DRM that offers secure content on any screen or platform; Streamkeeper Watermarking, which protects content with invisible client and server-side watermarking that can detect piracy; and Video Content Authority System (VCAS) for evolving networks. The company also provides threat defense solutions, such as App Shield that secures android and iOS apps; Code Shield, which secures code with an enterprise-grade security toolkit; Key Shield, that protects algorithm and builds secure cryptographic architectures; and Extended Threat Defense, a cybersecurity solution. It offers security solutions for various markets comprising automotive, e-sports and gaming, financial services, healthcare, Internet of Things, live sports, media and entertainment, pay TV, and streaming media, as well as for content owners. The company was formerly known as Inside Secure S.A. and changed its name to Verimatrix SA in July 2017. Verimatrix SA was incorporated in 1995 and is based in Meyreuil, France.

CAC 40 ended the session with VERIMATRIX rising 4.82% to €0.54 on Tuesday while CAC 40 rose 0.34% to €7,795.22.

Earnings Per Share

As for profitability, VERIMATRIX has a trailing twelve months EPS of €-0.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.99%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6%, now sitting on 62.74M for the twelve trailing months.

More news about VERIMATRIX.

9. LUMIBIRD (LBIRD.PA)

4.71% Price Change

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two segments, Photonics and Medical. The company offers solid-state and diode lasers, fiber lasers, fiber lasers/amplifiers and components, Laser rangefinder and LiDAR wind doppler LiDAR, medical and ophthalmological equipment. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The company was incorporated in 1970 and is headquartered in Lannion, France.

CAC 40 ended the session with LUMIBIRD jumping 4.71% to €12.90 on Tuesday while CAC 40 jumped 0.34% to €7,795.22.

Earnings Per Share

As for profitability, LUMIBIRD has a trailing twelve months EPS of €0.45.

PE Ratio

LUMIBIRD has a trailing twelve months price to earnings ratio of 28.67. Meaning, the purchaser of the share is investing €28.67 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.68%.

Yearly Top and Bottom Value

LUMIBIRD’s stock is valued at €12.90 at 21:40 EST, under its 52-week low of €13.04.

More news about LUMIBIRD.

10. MEMSCAP REGPT (MEMS.PA)

4.42% Price Change

MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical, and biomedical markets worldwide. The company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. It also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories. In addition, the company supplies optical MEMS chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user MEMS processes. Further, it offers mounting brackets, snap holders, non-sterile and sterile domes, and monitoring line sets. MEMSCAP, S.A. was founded in 1997 and is based in Crolles, France.

CAC 40 ended the session with MEMSCAP REGPT rising 4.42% to €8.52 on Tuesday while CAC 40 rose 0.34% to €7,795.22.

Earnings Per Share

As for profitability, MEMSCAP REGPT has a trailing twelve months EPS of €0.16.

PE Ratio

MEMSCAP REGPT has a trailing twelve months price to earnings ratio of 53.25. Meaning, the purchaser of the share is investing €53.25 for every euro of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 48.2%, now sitting on 14.07M for the twelve trailing months.

Yearly Top and Bottom Value

MEMSCAP REGPT’s stock is valued at €8.52 at 21:40 EST, higher than its 52-week high of €8.36.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEMSCAP REGPT’s stock is considered to be overbought (>=80).

More news about MEMSCAP REGPT.

Losers Today

1. PROACTIS SA (PROAC.PA)

-11.68% Price Change

Proactis SA provides source-to-pay software solution. It operates software platform that will give control over business spend. It also offers procurement solutions that provide purchasing professionals with the tools they need for purchasing process for routine goods and services, capital goods, and major projects. In addition, it offers invoice capture services, system administration, supplier onboarding, and tail spent management services. Further, Its solutions integrate with various ERP or financial systems. The company was formerly known as HUBWOO and changed its name to Proactis SA in January 2019. The company is based in Suresnes, France. Proactis SA operates as a subsidiary of Proactis Euro Hedgeco Limited.

CAC 40 ended the session with PROACTIS SA sliding 11.68% to €0.06 on Tuesday, following the last session’s upward trend. CAC 40 jumped 0.34% to €7,795.22, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, PROACTIS SA has a trailing twelve months EPS of €-0.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.88%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 14.11M for the twelve trailing months.

Moving Average

PROACTIS SA’s value is way under its 50-day moving average of €0.08 and way below its 200-day moving average of €0.09.

Volume

Today’s last reported volume for PROACTIS SA is 21057 which is 191% above its average volume of 7236.

Volatility

PROACTIS SA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.65%, a negative 1.49%, and a positive 8.25%.

PROACTIS SA’s highest amplitude of average volatility was 6.44% (last week), 11.13% (last month), and 8.25% (last quarter).

More news about PROACTIS SA.

2. VALNEVA (VLA.PA)

-8.89% Price Change

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.

CAC 40 ended the session with VALNEVA dropping 8.89% to €3.32 on Tuesday, after two successive sessions in a row of losses. CAC 40 rose 0.34% to €7,795.22, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, VALNEVA has a trailing twelve months EPS of €-0.82.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.81%.

Moving Average

VALNEVA’s value is way below its 50-day moving average of €5.81 and way below its 200-day moving average of €5.90.

Volatility

VALNEVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a negative 0.46%, and a positive 2.12%.

VALNEVA’s highest amplitude of average volatility was 1.87% (last week), 2.15% (last month), and 2.12% (last quarter).

More news about VALNEVA.

3. NORTHERN DRILLING (NODL.OL)

-8.54% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING sliding 8.54% to €0.44 on Tuesday while Oslo Børs Benchmark Index_GI fell 0.35% to €1,262.81.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-5.9.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Moving Average

NORTHERN DRILLING’s worth is way under its 50-day moving average of kr1.09 and way under its 200-day moving average of kr14.21.

More news about NORTHERN DRILLING.

4. BERGENBIO (BGBIO.OL)

-8.45% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO sliding 8.45% to €0.20 on Tuesday while Oslo Børs Benchmark Index_GI slid 0.35% to €1,262.81.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-0.55.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Moving Average

BERGENBIO’s value is way higher than its 50-day moving average of kr0.13 and way under its 200-day moving average of kr4.18.

More news about BERGENBIO.

5. EVERGREEN (EGR.PA)

-7.91% Price Change

Transition Evergreen SA is an infrastructure fund specializing in SMEs focused on the ecological transition. The firm focuses on accelerating the ecological transition and reducing the carbon footprint. The funds invest in unlisted French and European companies.

CAC 40 ended the session with EVERGREEN falling 7.91% to €1.98 on Tuesday, after three successive sessions in a row of losses. CAC 40 jumped 0.34% to €7,795.22, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, EVERGREEN has a trailing twelve months EPS of €0.16.

PE Ratio

EVERGREEN has a trailing twelve months price to earnings ratio of 12.38. Meaning, the purchaser of the share is investing €12.38 for every euro of annual earnings.

Volatility

EVERGREEN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.45%, a negative 0.70%, and a positive 1.38%.

EVERGREEN’s highest amplitude of average volatility was 3.03% (last week), 1.33% (last month), and 1.38% (last quarter).

Volume

Today’s last reported volume for EVERGREEN is 7921 which is 234.36% above its average volume of 2369.

Moving Average

EVERGREEN’s worth is way under its 50-day moving average of €2.43 and way below its 200-day moving average of €2.56.

More news about EVERGREEN.

6. VITURA (VTR.PA)

-7.89% Price Change

Founded in 2006, Vitura is a SIIC specializing in offices in Paris and Greater Paris. The total value of the portfolio was estimated as of June 30, 2023 at EUR 1,436 million excluding duties. Strongly committed to a sustainable development approach, Vitura has obtained the status of world No. 1 in the latest GRESB (Global Real Estate Sustainability Benchmark) ranking among listed office companies, as well as two Gold Awards from EPRA (European Public Real Estate Association) for the quality and transparency of its financial and non-financial communication.

CAC 40 ended the session with VITURA sliding 7.89% to €10.50 on Tuesday while CAC 40 jumped 0.34% to €7,795.22.

Earnings Per Share

As for profitability, VITURA has a trailing twelve months EPS of €-6.96.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.14%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.3%, now sitting on 75.63M for the twelve trailing months.

Moving Average

VITURA’s value is way under its 50-day moving average of €15.78 and way below its 200-day moving average of €18.15.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VITURA’s stock is considered to be oversold (<=20).

Volatility

VITURA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.08%, a negative 1.28%, and a positive 1.89%.

VITURA’s highest amplitude of average volatility was 7.96% (last week), 2.06% (last month), and 1.89% (last quarter).

More news about VITURA.

7. METABOLIC EXPLORER (METEX.PA)

-7.78% Price Change

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER sliding 7.78% to €0.35 on Tuesday, after five sequential sessions in a row of losses. CAC 40 rose 0.34% to €7,795.22, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.

Volume

Today’s last reported volume for METABOLIC EXPLORER is 171627 which is 5.49% above its average volume of 162691.

Yearly Top and Bottom Value

METABOLIC EXPLORER’s stock is valued at €0.35 at 21:40 EST, way under its 52-week high of €1.42 and way higher than its 52-week low of €0.22.

Volatility

METABOLIC EXPLORER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.55%, a positive 0.17%, and a positive 4.78%.

METABOLIC EXPLORER’s highest amplitude of average volatility was 8.55% (last week), 5.89% (last month), and 4.78% (last quarter).

More news about METABOLIC EXPLORER.

8. ATOS (ATO.PA)

-7.34% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS dropping 7.34% to €2.18 on Tuesday, following the last session’s downward trend. CAC 40 jumped 0.34% to €7,795.22, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-10.01.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATOS’s stock is considered to be overbought (>=80).

More news about ATOS.

9. FUT.CLUBE PORTO (FCP.LS)

-7.32% Price Change

Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.

PSI ended the session with FUT.CLUBE PORTO sliding 7.32% to €1.14 on Tuesday while PSI slid 0.32% to €6,226.09.

Earnings Per Share

As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €0.94.

PE Ratio

FUT.CLUBE PORTO has a trailing twelve months price to earnings ratio of 1.21. Meaning, the purchaser of the share is investing €1.21 for every euro of annual earnings.

More news about FUT.CLUBE PORTO.

10. FERMENTALG (FALG.PA)

-6.75% Price Change

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

CAC 40 ended the session with FERMENTALG falling 6.75% to €0.72 on Tuesday while CAC 40 rose 0.34% to €7,795.22.

Earnings Per Share

As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FERMENTALG’s stock is considered to be overbought (>=80).

More news about FERMENTALG.

Stay up to date with our winners and losers daily report